FDA Authorizes Moderna, Janssen COVID-19 Booster Shots, Allows for Mix and Match
The decision comes following the results of two FDA advisory committee meetings.
Diagnosis & Disease Information
Second Dose of COVID-19 Vaccine Not Enough for Some Patients With Cancer
About half of patients with impaired seroconversion after the first dose of a COVID-19 vaccine still had low antibody levels after the second dose.
NASEM: Building Parents’ Confidence in COVID-19 Vaccines
Having the tough conversations. NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
FDA Committee Supports Janssen COVID-19 Vaccine Booster
The panel reviewed safety and efficacy data from the phase 3 ENSEMBLE 2 study.
Pfizer-BioNTech Submit Request for Emergency Use of Pediatric COVID-19 Vaccine
The Companies recently submitted data from a phase 2/3 trial that included 2268 pediatric participants.
FDA Panel to Discuss Boosters, COVID-19 Vaccine for Children in Upcoming Meetings
Background materials for both meetings will be available to the public.
Survey Shows High Level of Parental Hesitancy for COVID-19 Vaccines
The survey asked about the likelihood of both child and parental vaccination, perceptions about the vaccines and the level of trust in various sources of information.
Lower Dose COVID-19 Vaccine Appears Safe, Immunogenic in Children 5 to 11 Years Old
Participants 5 to 11 years of age received a 2-dose regimen of 10mcg administered 21 days apart.
Comparison of Hospital Treatment of Alpha vs Delta COVID-19 Variants
Researchers sought to compare the risk for hospital and emergency department admission for the treatment of COVID-19 among patients infected with the Alpha variant vs those with the Delta variant.
Moderna Submits COVID-19 Vaccine Booster Data for FDA Review
A single 50µg dose of mRNA-1273 given as a booster increased neutralizing antibody titer responses above the phase 3 benchmark.
- Loading...
Loading...
Next post in News
Loading... 
Loading...